YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
Qian Lei(Zhongnan Hospital of Wuhan University), Luoting Yu(State Key Laboratory of Biotherapy), Tiantao Gao(Sichuan University), Wei Wei(State Key Laboratory of Biotherapy), Zhihao Liu(Sichuan University), Xuejiao Song(Sichuan University), Cuiting Peng(Sichuan University), Zhongping Li(Sichuan University), Yong Xia, Zhanzhan Feng(Sichuan University), Tinghong Ye(State Key Laboratory of Biotherapy), Lu Xiong(Sichuan University), Ningyu Wang(Southwest Jiaotong University)
Cited by 65
Related Papers
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
|PLoS ONE|2014|131
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
|Journal of Medicinal Chemistry|2021|116
The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis
|Cell Death and Disease|2018|87
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
|Scientific Reports|2016|72
Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents
|Bioorganic & Medicinal Chemistry Letters|2013|66